|
Market Closed -
Nyse
01:30:02 16/05/2026 am IST
|
5-day change
|
1st Jan Change
|
|
143.47 USD
|
-0.69%
|
 |
-3.99%
|
-26.07%
|
|
13/05 |
Becton, Dickinson and Company Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08:40 AM
| | |
12/05 |
Becton Dickinson Euro Finance S.À R.L files for euro-denominated 600 million 3.855% notes offering due 2033 - SEC filing
|
RE
| |
08/05 |
Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says
|
MT
| |
07/05 |
Becton, Dickinson Shares Rise After Higher Fiscal Q2 Results; Vitor Roque Named as CFO
|
MT
| |
07/05 |
Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180
|
MT
| |
07/05 |
Becton Dickinson raises 2026 profit forecast on drug delivery devices demand
|
RE
| |
07/05 |
Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215
|
MT
| |
07/05 |
Becton, Dickinson and Company, Q2 2026 Earnings Call, May 07, 2026
| | |
07/05 |
Becton, Dickinson and Company Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026
|
CI
| |
07/05 |
Becton, Dickinson and Company Appoints Vitor Roque as Chief Financial Officer, Effective May 7, 2026
|
CI
| |
07/05 |
Becton, Dickinson and Company Appoints Vitor Roque as Executive Vice President, Effective May 7, 2026
|
CI
| |
07/05 |
Becton Dickinson raises annual profit forecast on strength in drug delivery devices
|
RE
| |
07/05 |
Becton, Dickinson Fiscal Q2 Adjusted Earnings, Revenue Rise; Names Vitor Roque CFO
|
MT
| |
07/05 |
Earnings Flash (BDX) Becton, Dickinson and Company Reports Q2 Revenue $4.71B, vs. FactSet Est of $4.67B
|
MT
| |
07/05 |
Earnings Flash (BDX) Becton, Dickinson and Company Posts Q2 Adjusted EPS $2.90 per Share
|
MT
| |
07/05 |
Becton Dickinson: Fiscal Q2 Earnings Snapshot
|
AQ
| |
07/05 |
Becton Dickinson and : Earnings Release Q2 FY26
|
PU
| |
07/05 |
Becton Dickinson and : Presentation Q2 FY26
|
PU
| |
07/05 |
BD Appoints Vitor Roque Chief Financial Officer
|
PR
| |
07/05 |
BD Reports Second Quarter Fiscal 2026 Financial Results
|
PR
| |
07/05 |
Becton, Dickinson and Company Reaffirms Revenue Growth Guidance for the Full Year Fiscal 2026
|
CI
| |
05/05 |
Becton, Dickinson Collaborates With Wellstar Health to Improve Drug Delivery Systems
|
MT
| |
05/05 |
BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI
|
PR
| |
05/05 |
BD and Wellstar Health System Enter Strategic Partnership to Advance Medication Management
|
CI
| |
04/05 |
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
